The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 752K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

72 articles for Q Yang


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.EBI
Beijing Institute of Technology
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.EBI
Fudan University
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design.EBI
Cubist Pharmaceuticals
Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis.EBI
Sichuan University
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.EBI
Beijing Pearl Biotech
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.EBI
Cubist Pharmaceuticals
Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.EBI
Cubist Pharmaceuticals
Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO).EBI
Zhengzhou University
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.EBI
Beijing Pearl Biotech
Polyketides witha-Glucosidase Inhibitory Activity from a Mangrove Endophytic Fungus, Penicillium sp. HN29-3B1.EBI
Hebei University
Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs.EBI
Peking University
Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I).EBI
China Pharmaceutical University
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.EBI
Fudan University
Synthesis and enzymatic evaluation of phosphoramidon and itsß anomer: Anomerization ofa-l-rhamnose triacetate upon phosphitylation.EBI
Jiangxi Science and Technology Normal University
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides.EBI
TBA
Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1.EBI
TBA
Studies on gambogic acid (IV): Exploring structure-activity relationship with I¿B kinase-beta (IKKß).EBI
China Pharmaceutical University
Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.EBI
Fudan University
Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.EBI
Lexicon Pharmaceuticals
Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers.EBI
China Pharmaceutical University
Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.EBI
Lexicon Pharmaceuticals
Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.EBI
Harvard Medical School
Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.EBI
The Scripps Research Institute
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.EBI
Pfizer
Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors.EBI
China Pharmaceutical University
Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability.EBI
Shandong University
Exploration and Biological Evaluation of 1,3-Diamino-7EBI
Chinese Academy of Medical Sciences&Peking Union Medical College
Targeting VPS34 in autophagy: An update on pharmacological small-molecule compounds.EBI
Southwest Jiaotong University
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss.EBI
Pfizer
Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors.EBI
China Agricultural University
Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors.EBI
Soochow University
Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists.EBI
Affiliated Tumor Hospital of Guangxi Medical University
Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents.EBI
Jiangsu Normal University
Optimization of Beclin 1-Targeting Stapled Peptides by Staple Scanning Leads to Enhanced Antiproliferative Potency in Cancer Cells.EBI
Fudan University
Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.EBI
Soochow University
Design, synthesis, and biological evaluation of novel sulindac derivatives as partial agonists of PPARγ with potential anti-diabetic efficacy.EBI
Xiamen University
Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents.EBI
Jiangnan University
Stapled and EBI
Jiangsu Normal University
Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947.EBI
Merck
Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.EBI
Tongji University
2-(4-Fluorophenyl)-quinazolin-4(3H)-one as a novel tyrosinase inhibitor: Synthesis, inhibitory activity, and mechanism.EBI
Jiangxi Normal University
Design, synthesis and biological evaluation of tetrazole-containing RXRα ligands as anticancer agents.EBI
Xiamen University
Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.EBI
Yunnan University
Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.EBI
Fudan University
A Series of Compounds Bearing a Dipyrido-Pyrimidine Scaffold Acting as Novel Human and Insect Pest Chitinase Inhibitors.EBI
Dalian University of Technology
-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase.EBI
Fudan University
5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.EBI
Ligand Pharmaceuticals
Modification of the Thioglycosyl-Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors.EBI
China Agricultural University
Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.EBI
Universities of Shandong
Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres.EBI
Pfizer
Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.EBI
Aarhus University
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.EBI
Cubist Pharmaceuticals
Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors.EBI
China Pharmaceutical University
Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase.EBI
East China University of Science and Technology
Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species.EBI
Florida A and M University
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.EBI
Nantong University
Selective inhibition of β-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.EBI
Dalian University of Technology
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.EBI
Novartis Institutes For Biomedical Research
BCL-2 InhibitorsBDB
Eil Therapeutics
AROMATIC VINYL COMPOUND, METAL COMPLEX THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOFBDB
Shanghai Maxinovel Pharmaceuticals Co.
MEDICAL USE OF N4-HYDROXY CITICOLINE COMPOUNDSBDB
Immunic
Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereofBDB
Syntara
MACROCYCLIC COMPOUNDBDB
Asahi Kasei Pharma
PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOFBDB
Sichuan Kelun-Biotech Biopharmaceutical
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitorsBDB
Ksq Therapeutics
4H-pyrrolo[3,2-c]pyridin-4-one derivativesBDB
Bayer Aktiengesellschaft
Quinoline compounds as modulators of RAGE activity and uses thereofBDB
TBA
Androgen receptor modulating compoundsBDB
Orion
2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereofBDB
Shanghai Haiyan Pharmaceutical Technology
Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseasesBDB
TBA
Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1.BDB
Merck Research Laboratories
Biexponential kinetics of (R)-alpha-[3H]methylhistamine binding to the rat brain H3 histamine receptor.BDB
Schering-Plough Research Institute